How do I find out if I qualify for a metastatic castration-resistant prostate cancer study in Illinois?

Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.

Do I have to live in Illinois to take part?

Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.

Does it cost anything to join a metastatic castration-resistant prostate cancer trial?

Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Clinical trials · Illinois

Metastatic Castration-resistant Prostate Cancer clinical trials in Illinois

We’re tracking 28 recruiting metastatic castration-resistant prostate cancer studies with a site in Illinois — including Phase 1 and Phase 3 studies, each written for real people, not researchers.

Recruiting studies in Illinois

NCT06136624RecruitingPhase 3
Comparing a new drug to standard hormone therapy for advanced prostate cancer
This trial tests a new pill, opevesostat, against other hormone treatments for men with metastatic castration-resistant prostate cancer that has progressed after previous therapies. It aims to see which approach works better.
Chicago, IllinoisAges 18 years+
NCT05983432RecruitingPhase 1
Study of BL-B01D1 for advanced lung and other solid tumors
This trial tests an experimental drug called BL-B01D1 for people with several types of advanced solid tumors, especially non-small cell lung cancer and breast cancer. It's designed for those whose cancer has continued to grow after standard treatments.
Chicago, IllinoisAges 18 years+
NCT06855277RecruitingPhase 3
AAA817 with hormone therapy for advanced prostate cancer
This trial tests a new combination treatment (AAA817 plus a hormone therapy) against standard care for men with advanced PSMA-positive prostate cancer that has spread and stopped responding to a previous hormone therapy. It may be an option if you haven't had certain prior treatments.
Chicago, IllinoisAges 18–100
NCT05939414RecruitingPhase 3
Study of radioactive drug for prostate cancer that has spread a little
This study tests a radioactive drug (177Lu-PSMA-617) compared to no immediate treatment in men with prostate cancer that has returned and spread to a few spots (oligometastatic). It aims to see if this treatment delays the spread of cancer and improves outcomes.
Elk Grove, IllinoisAges 18–100

Metastatic Castration-resistant Prostate Cancer trials by city in Illinois

Chicago

Where these studies are running in Illinois

Institutions with a site for the recruiting metastatic castration-resistant prostate cancer studies listed above.

Northwestern University · 2 studies
The Cancer Institute of Alexian Brothers
University of Chicago
University of Chicago Medical Center ( Site 0045)
University of Illinois at Chicago
University of Illinois Cancer Center at Chicago

What taking part in a metastatic castration-resistant prostate cancer study involves

A screening visit first

Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.

Care at a nearby site

Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.

You stay in control

Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.

The team decides eligibility

Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.

Metastatic Castration-resistant Prostate Cancer trials in other states

Common questions

Are there metastatic castration-resistant prostate cancer clinical trials in Illinois?: Yes. We're currently tracking 28 recruiting metastatic castration-resistant prostate cancer studies with a site in Illinois, each rewritten in plain language so you can see what it's testing and who it's for.
How do I find out if I qualify for a metastatic castration-resistant prostate cancer study in Illinois?: Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
Do I have to live in Illinois to take part?: Not necessarily. These studies have a site in Illinois, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
Does it cost anything to join a metastatic castration-resistant prostate cancer trial?: Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.

Not the right time?

New metastatic castration-resistant prostate cancer studies open in Illinois regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.

Get told when a study that fits you opens

Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.